IPO Advisory
In-depth, experienced and seamless execution throughout the IPO Process.
Concord Biotech Limited is an Pharmaceutical based company, located in Ahmedabad, Concord Biotech Limited IPO size was 1551.00 Cr. and was issued at 741.00 per share. The share of Concord Biotech Limited were listed at 941.85 per share and are currently trading at 2059.10 per share.
*CAGR is calculated basis issue price at the time of IPO and Current Market Price without taking into Consideration Bonus/Right issue.
Concord Biotech operates in Pharmaceutical and Biopharma Company Having Many Niche Products. The Issue is listed on MainBoard in Aug, 2023. Concord Biotech IPO size was 1551.00 Cr. with Issue price of 741.00 .
Merchant Banker(s) of Concord Biotech IPO: Citigroup Global Markets India Private Limited , Jefferies India Private Limited , Kotak Mahindra Capital Company Limited
Concord Biotech IPO subscription was 24.87 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Concord Biotech IPO listed at a listing price of 941.85 against the offer price of 741.00.
The current market price of Concord Biotech is 2059.10.
Why Us?
